Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.
Gurney JG, Bass JK, Onar-Thomas A, Huang J, Chintagumpala M, Bouffet E, Hassall T, Gururangan S, Heath JA, Kellie S, Cohn R, Fisher MJ, Panandiker AP, Merchant TE, Srinivasan A, Wetmore C, Qaddoumi I, Stewart CF, Armstrong GT, Broniscer A, Gajjar A. Gurney JG, et al. Among authors: gururangan s. Neuro Oncol. 2014 Jun;16(6):848-55. doi: 10.1093/neuonc/not241. Epub 2014 Jan 10. Neuro Oncol. 2014. PMID: 24414535 Free PMC article. Clinical Trial.
Primary hepatic tumours in children: a 26-year review.
Gururangan S, O'Meara A, MacMahon C, Guiney EJ, O'Donnell B, Fitzgerald RJ, Breatnach F. Gururangan S, et al. J Surg Oncol. 1992 May;50(1):30-6. doi: 10.1002/jso.2930500111. J Surg Oncol. 1992. PMID: 1315408 Review.
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.
Gururangan S, Cokgor L, Rich JN, Edwards S, Affronti ML, Quinn JA, Herndon JE 2nd, Provenzale JM, McLendon RE, Tourt-Uhlig S, Sampson JH, Stafford-Fox V, Zaknoen S, Early M, Friedman AH, Friedman HS. Gururangan S, et al. Neuro Oncol. 2001 Oct;3(4):246-50. doi: 10.1093/neuonc/3.4.246. Neuro Oncol. 2001. PMID: 11584894 Free PMC article. Clinical Trial.
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE, McLendon RE, Provenzale JM, Rich JN, Sampson JH, Gururangan S, Dowell JM, Salvado A, Friedman HS, Reardon DA. Desjardins A, et al. Among authors: gururangan s. J Neurooncol. 2007 May;83(1):53-60. doi: 10.1007/s11060-006-9302-2. Epub 2007 Jan 24. J Neurooncol. 2007. PMID: 17245623 Clinical Trial.
Temozolomide in children with progressive low-grade glioma.
Gururangan S, Fisher MJ, Allen JC, Herndon JE 2nd, Quinn JA, Reardon DA, Vredenburgh JJ, Desjardins A, Phillips PC, Watral MA, Krauser JM, Friedman AH, Friedman HS. Gururangan S, et al. Neuro Oncol. 2007 Apr;9(2):161-8. doi: 10.1215/15228517-2006-030. Epub 2007 Mar 8. Neuro Oncol. 2007. PMID: 17347491 Free PMC article. Clinical Trial.
Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation.
Gururangan S, Frankel W, Broaddus R, Clendenning M, Senter L, McDonald M, Eastwood J, Reardon D, Vredenburgh J, Quinn J, Friedman HS. Gururangan S, et al. Neuro Oncol. 2008 Feb;10(1):93-7. doi: 10.1215/15228517-2007-037. Epub 2007 Nov 9. Neuro Oncol. 2008. PMID: 17993636 Free PMC article.
Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.
Broniscer A, Gururangan S, MacDonald TJ, Goldman S, Packer RJ, Stewart CF, Wallace D, Danks MK, Friedman HS, Poussaint TY, Kun LE, Boyett JM, Gajjar A. Broniscer A, et al. Among authors: gururangan s. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6712-8. doi: 10.1158/1078-0432.CCR-07-1016. Clin Cancer Res. 2007. PMID: 18006772 Clinical Trial.
Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study.
Gururangan S, Turner CD, Stewart CF, O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R, Pollack IF, Blaney SM, Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LE. Gururangan S, et al. Clin Cancer Res. 2008 Feb 15;14(4):1124-30. doi: 10.1158/1078-0432.CCR-07-4242. Clin Cancer Res. 2008. PMID: 18281546 Clinical Trial.
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
Fouladi M, Chintagumpala M, Ashley D, Kellie S, Gururangan S, Hassall T, Gronewold L, Stewart CF, Wallace D, Broniscer A, Hale GA, Kasow KA, Merchant TE, Morris B, Krasin M, Kun LE, Boyett JM, Gajjar A. Fouladi M, et al. Among authors: gururangan s. J Clin Oncol. 2008 Aug 1;26(22):3749-55. doi: 10.1200/JCO.2007.14.3974. J Clin Oncol. 2008. PMID: 18669462 Free PMC article. Clinical Trial.
143 results